Uveitis Market By 2024

More documents

Recommendations

Info

P e r s i s t e n c e M a r k e t R e s e a r c h Asia Pacific (APAC) Middle East and Africa (MEA) North America, the largest and fastest growing regional market for uveitis treatment globally, will retain its dominant position over the assessed period. With over 34% market value share in 2024, this regional will possibly account for around US$ 290 Mn. Europe will remain the second key market with nearly 27% share by the end of forecast period, followed by Asia Pacific. View Report Table of Contents, Figures, and Tables The report profiles key market players and highlights their recent activities supporting market growth. Allergan, Inc., Novartis AG (ALCON), Valeant Pharmaceuticals International, Inc., AbbVie Inc., Eyegate Pharmaceuticals, Inc., Alimera Sciences Inc., and pSivida Corp. are some of the key players in the global uveitis treatment market. Request to View Tables of Content @ http://www.persistencemarketresearch.com/marketresearch/uveitis-market/toc Among these, Allergan, Valeant, and Novartis constitute the most prominent companies. Eyegate is also actively involved through strategic acquisitions. Allergan, in 2016, acquired a gene therapy company RetroSense Therapeutics to enhance the company’s eye care product pipeline. Later, the same year, Allergan launched an influential uveitis drug Taytulla. Novartis recently acquired Encore Vision, Inc. in 2016, to strengthen its ophthalmology pipeline. Recently in 2015, Eyegate signed a licensing agreement with Valeant for an effective combination product against uveitis. More recently in 2016, the company announced the acquisition of Jade Therapeutics, Inc. and stepped into treatment for poorly-served ophthalmic indications. Browse Complete Report @ http://www.persistencemarketresearch.com/marketresearch/uveitis-market.asp About Us: Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. North America Wound Debridement Products Market by 2024
P e r s i s t e n c e M a r k e t R e s e a r c h To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes. Our offerings include pre-built reports that address every major sale, customized solutions to cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration research approach for exploring emerging technologies has allowed us to solve the most complex problems of clients. We do not follow a reactive approach, but a pro-active one. Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and provide the latest insights into these technologies when they are being commercialized. Our ground-breaking approach allows us to deliver market solutions before the technologies reach the market. Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset. Contact Us: Persistence Market Research 90 Sate Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 Email: sales@persistencemarketresearch.com Website: http://www.persistencemarketresearch.com/ media@persistencemarketresearch.com Stay updated with our official Blog: http://pmrblog.com North America Wound Debridement Products Market by 2024
Page 1 and 2: Global Market Study on Uveitis Trea
Page 3: P e r s i s t e n c e M a r k e t R

Uveitis Market By 2024

Create successful ePaper yourself

Delete template?

Save as template?